Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu
PaperCitations, authors & open-access status
Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 414 citations, 2010 year and closed oa status.
414
Citations
2010
Year
closed
OA Status